Last week, readers were most interested in a story about the overturning by a federal court of the FDA's LDT rule.

The assays measure phosphorylated tau 181 and apolipoprotein 4 to rule out whether a patient has Alzheimer's disease.

While AI-based tools have become widely used for documentation and clerical tasks, developers and healthcare experts see a greater future role in clinical care.

The firm said that investors provided better-than-expected backing as the company anticipates growing use of its digital pathology platform in 2025.

NEW YORK – With the launch of its first product, a rule-out test for pancreatic cysts that can help risk-stratify patients who may have pancreatic cancer, Purdue University spinout Amplified Sciences ...

The automated DxC 500 I analyzer has a throughput of up to 800 clinical chemistry tests and 100 immunoassays per hour.

The Switzerland-based firm's MosaiQ AiPlex Connective Tissue Diseases (CTDplus) assay is used to aid the diagnosis of autoimmune diseases.

The firm's Innovance Antithrombin assay is used to monitor antithrombin activity levels in hemophilia patients and aid dosing decisions for a routine prophylaxis.

The company presented its results this week at a conference and anticipates that with additional validation early next year, it will be ready to file for regulatory approval.

The aggregate repurchase authorization program now totals $200 million, which the firm will fund with cash and cash equivalents.

Last week, readers were most interested in a story about the potentially devastating effects that cuts in US funding for tuberculosis may have.

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.